Related Experiment Video
Updated: Mar 2, 2026

Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Reduced Cardiovascular Functions in Patients with Alzheimer's Disease
Insights
Cardiovascular health impacts Alzheimer's disease (AD) risk. Lower heart function and reduced cerebral blood flow are linked to AD, suggesting improved cardiovascular care may help prevent and treat the disease.
Area of Science:
- Neurology
- Cardiology
- Vascular Biology
Background:
- Cardiovascular functions are implicated in Alzheimer's disease (AD) pathogenesis.
- The precise relationship between cardiac function, cerebral blood flow, and AD remains incompletely understood.
Purpose of the Study:
- To investigate the association between cardiac function, cerebral hemodynamics, and Alzheimer's disease.
- To identify specific cardiovascular and cerebrovascular markers related to AD.
Main Methods:
- Echocardiography measured ejection fraction in AD patients (n=34) and controls (n=34).
- Transcranial Doppler assessed basilar artery (BA), left (LTICA), and right (RTICA) terminal internal carotid artery velocities, pulsatility index (PI), and resistance index (RI).
- Brain MRI and CT angiography evaluated vascular factors like plaques and ischemic lesions.
Main Results:
- AD patients exhibited lower ejection fractions and cerebral blood flow velocities compared to controls.
- AD patients showed higher RI and PI in the BA, LTICA, and RTICA, alongside increased arterial plaques.
- Ejection fraction and mean velocity in BA and LTICA were independently associated with AD after multivariate adjustment.
Conclusions:
- Impaired heart function and altered cerebral blood flow are significantly associated with Alzheimer's disease.
- These findings highlight the critical role of cardiovascular health in AD pathogenesis.
- Enhancing cardiovascular function may offer a potential therapeutic strategy for AD prevention and treatment.
Abstract:
Previous studies have suggested that cardiovascular functions might play a critical role in Alzheimer's disease (AD) pathogenesis. However, the relationship among heart function, blood flow of cerebral vessels, and AD remains unclear. In the present study, AD patients (n = 34) and age- and gender-matched cognitively normal controls (n = 34) were recruited. Demographic and comorbidity information was collected. The ejection fraction was measured using echocardiography, and the mean velocity, pulsatility index (PI), and resistance index (RI) of the basilar artery (BA), left terminal internal carotid artery (LTICA), and right terminal internal carotid artery (RTICA) were measured using transcranial Doppler. The data of lacunae, white matter changes, and plaques in the aortic arch and carotid arteries were collected from brain magnetic resonance imaging and computed tomography angiography images. Compared with normal controls, AD patients had lower ejection fractions and cerebral blood flow velocities and higher RI and PI in the BA, LTICA, and RTICA, as well as more plaques in the aortic and carotid arteries. In the multivariate logistic regression analysis, the ejection fraction and the mean velocity of the BA and LTICA were independently associated with AD after adjusting for age, gender, education, vascular risk factors, arterial plaques, and brain ischemic lesions detected in the brain images. These findings suggest that heart function and vascular condition may play important roles in AD pathogenesis. Improving cardiovascular functions could be a promising approach for the prevention and treatment of AD.
More Related Videos
07:30Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Atherosclerosis III: Management
Alzheimer's Disease: Treatment
Pharmacodynamics in Geriatric Patients: Effects of Age
Dementia
The progression of dementia is generally gradual....
Drug Dosing: Geriatric Patients